clinical chemistry screen
| Head | ||
|
||
| Mailing adresses | ||
|
||
| Scientist | ||
|
||
| Homepage | ||
| Clinical Chemistry | ||
The aim of the Clinical-Chemical Screen is the detection of hematological changes, defects of various organ systems, and changes in metabolic pathways and electrolyte homeostasis by means of suitable laboratory diagnostic tools. The methods used are routine procedures, allowing the appropriate screen of large numbers of mice for a broad spectrum of clinical-chemical and hematological parameters.
|
||
| Primary Screen | ||
|
Pipeline I: Intraperitoneal Glucose Tolerance Test A glucose tolerance test using a simplified protocol is performed in collaboration with the Metabolic Screen to detect subclinical diabetes and impaired glucose tolerance.
Pipeline II: Clinical-Chemical and Haematological Investigations Required quantity: At least 130µl plasma in 1.5ml Eppendorf-tubes and 50µl blood in EDTA-coated tubes are required
|
||
| Secondary Screen | ||
|
||
The following parameters which can be tested with the AU400 as well are not included in the primary screen:
In Plasma/Serum: Magnesium, Bicarbonate, Creatine Kinase (CK), Lipase, HDL-Cholesterol, LDL-Cholesterol, Ferritin, Transferrin, Unsaturated Iron Binding Capacity (UIBC), C Reactive Protein (CRP), Total Bilirubin, Direct Bilirubin
In Urine: Specific Weight, Sodium, Potassium, Chloride, Calcium, Inorganic Phosphate, Total Protein, Albumin, Creatinine, Urea, Uric Acid, Glucose, α-Amylase
If the Primary Screen provides interesting results the following in-depth analysis can be offered:
|
||


